PCDC: Protect Critical 340B Savings that Help Providers Serve New York’s Most Vulnerable Communities

Categories: Policy
In a letter to New York Governor Andrew Cuomo, PCDC stressed the devastating impact the proposed Medicaid pharmacy benefit transition will have on safety net providers across the state. The pharmacy transition from Medicaid managed care to fee-for-service, otherwise known as the “carve out,” is set to take effect on April 1, 2021, and would …

Read More

PCDC: Protect 340B Reimbursement for Safety Net Hospitals

Categories: Policy
Reducing reimbursement for safety net hospitals that are already distressed from the impact of COVID-19 would harm the underserved communities they serve, said PCDC in a public comment recently submitted to the Seema Verma, Administrator of the Centers for Medicare and Medicaid Services (CMS). The comment was in response to the most recent proposed Hospital …

Read More

PCDC Urges Delay in Medi-Cal Pharmacy Transition to Support COVID-19 Response

Categories: Policy
In an urgent letter to the California legislative budget leadership, PCDC urges the California legislature to delay the Medi-Cal pharmacy transition included in the state budget proposal. Governor Gavin Newsom’s 2020-2021 budget proposal directs the Department of Health Care Services (DHCS) to transition all pharmacy services for Medi-Cal managed care to Fee For Service (FFS) …

Read More

PCDC: Protect 340B Medi-Cal Savings for California’s Low-Income Communities

Categories: Policy
In a public comment to the California Department of Health Care Services (DHCS) Stakeholder Advisory Committee Meeting, PCDC stresses the importance of the 340B Drug Discount Program and the ramifications of its elimination on low-income communities. PCDC commended Governor Newsom’s vision to transform the health care system and promote affordable and accessible health care for all, …

Read More

Keep a Watchful Eye on 340B Drug Discount Program

Categories: Policy
On July 13, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would drastically cut the 340B drug discount program for hospitals serving Medicare patients. While the proposed CMS rule would not affect community health centers or other 340B-covered entities and Health Resources and Services Administration (HRSA) grantees, the Primary Care …

Read More